SLFN12 and prostate cancer: Overexpressing SLFN12 in prostate cancer LNCaP and PC-3 cells induces the differentiation of these cells as indicated by the reduced PSA expression and increased dipeptidyl-peptidase-4 and E-cadherin expression independently of the other known differentiation pathways [92].